Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop
In this week’s issue of The Savvy Diabetic: GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs...
Savvy Updates, 9/23/24: G7 Geofencing Fix, Senseonics Eversense 365, Abbott Ramps Libre3 Production, AI Predicts Retinopathy, SuperCell Medicines, Stem Cell-Enabled Therapy, How to Appeal Insurance Denial, T1D & Brain Development, FTC & PMBs Sue Each Other, ChatGPT for Diagnosis
In this week’s issue of The Savvy Diabetic: Geofencing/Dexcom G7 Update! with Jake Leach Senseonics Gets FDA Clearance for 1-year CGM Abbott Ramps Up Libre 3 Production AI Model to Predict Diabetic Retinopathy GC Therapeutics “Supercell”...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder
Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely
Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024. Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89...
Savvy Updates 8/19/24: Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED
Tandem warns iPhone app still draining insulin pump batteries by Elise Reuter for MedTechDive.com, 15 August 2024. Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected...
More Diabetes Blogs